Vasorelaxant Activity of (2S)-Sakuranetin and Other Flavonoids Isolated from the Green Propolis of the Caatinga Mimosa tenuiflora
Planta Medica · 01.05.2024 · 90 (06) · 454-468
DOI: 10.1055/a-2294-7042 ↗Kurz gefasst
Fachartikel in der Zeitschrift Planta Medica, erschienen am 01.05.2024. Verfasst von Ninh The Son und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Chemistry, Vietnam Academy of Science and Technology (VAST), Hanoi, Vietnam. Hauptthemen laut MEDLINE: Flavonoids, Vasodilator Agents, Propolis, Molecular Docking Simulation. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: São Paulo Research Foundation, National Council for Scientific and Technological Development, Coordination for the Improvement of Higher Education Personnel.
Abstract (Originalsprache)
Some in vitro and in vivo evidence is consistent with the cardiovascular beneficial activity of propolis. As the single actors responsible for this effect have never been identified, an in-depth investigation of flavonoids isolated from the green propolis of the Caatinga Mimosa tenuiflora was performed and their mechanism of action was described. A comprehensive electrophysiology, functional, and molecular docking approach was applied. Most flavanones and flavones were effective CaV1.2 channel blockers with a potency order of (2S)-sakuranetin > eriodictyol-7,3′-methyl ether > quercetin 3-methyl ether > 5,4′-dihydroxy-6,7-dimethoxyflavanone > santin > axillarin > penduletin > kumatakenin, ermanin and viscosine being weak or modest stimulators. Except for eriodictyol 5-O-methyl ether, all the flavonoids were also effective spasmolytic agents of vascular rings, kumatakenin and viscosine also showing an endothelium-dependent activity. (2S)-Sakuranetin also stimulated KCa1.1 channels both in single myocytes and vascular rings. In silico analysis provided interesting insights into the mode of action of (2S)-sakuranetin within both CaV1.2 and KCa1.1 channels. The green propolis of the Caatinga Mimosa tenuiflora is a valuable source of multi-target vasoactive flavonoids: this evidence reinforces its nutraceutical value in the cardiovascular disease prevention arena.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute of Chemistry, Vietnam Academy of Science and Technology (VAST), Hanoi, Vietnam.
- Department of Chemistry, Graduate University of Science and Technology, Vietnam Academy of Science and Technology, Caugiay, Hanoi, Vietnam.
- Dipartimento di Biotecnologie, Chimica e Farmacia, Università di Siena, Siena, Italy.
- Dipartimento di Scienze della Vita, Università di Siena, Siena, Italy.
- School of Pharmaceutical Sciences of Ribeirão Preto, Ribeirão Preto, University of São Paulo, Ribeirão Preto-SP, Brazil.
Förderung
- São Paulo Research Foundation
- National Council for Scientific and Technological Development
- Coordination for the Improvement of Higher Education Personnel
Zitieren
APA
Son, N. T., Gianibbi, B., Panti, A., Spiga, O., Bastos, J. K., & Fusi, F. (2024). Vasorelaxant Activity of (2S)-Sakuranetin and Other Flavonoids Isolated from the Green Propolis of the Caatinga Mimosa tenuiflora. Planta Medica, 90(06), 454-468. https://doi.org/10.1055/a-2294-7042
Vancouver
Son NT, Gianibbi B, Panti A, Spiga O, Bastos JK, Fusi F. Vasorelaxant Activity of (2S)-Sakuranetin and Other Flavonoids Isolated from the Green Propolis of the Caatinga Mimosa tenuiflora. Planta Medica. 2024;90(06):454-468. doi:10.1055/a-2294-7042
BibTeX
@article{Son2024,
author = {Son, Ninh The and Gianibbi, Beatrice and Panti, Alice and Spiga, Ottavia and Bastos, Jairo Kenupp and Fusi, Fabio},
title = {Vasorelaxant Activity of (2S)-Sakuranetin and Other Flavonoids Isolated from the Green Propolis of the Caatinga Mimosa tenuiflora},
journal = {Planta Medica},
year = {2024},
volume = {90},
number = {06},
pages = {454--468},
doi = {10.1055/a-2294-7042}
}
EUVIMED